These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 37004461

  • 41. Group-based treatment of opioid use disorder with buprenorphine: A systematic review.
    Sokol R, LaVertu AE, Morrill D, Albanese C, Schuman-Olivier Z.
    J Subst Abuse Treat; 2018 Jan; 84():78-87. PubMed ID: 29195596
    [Abstract] [Full Text] [Related]

  • 42. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
    Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA.
    JAMA Netw Open; 2022 May 02; 5(5):e2211363. PubMed ID: 35536575
    [Abstract] [Full Text] [Related]

  • 43. Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
    Nunes EV, Levin FR, Reilly MP, El-Bassel N.
    J Subst Abuse Treat; 2021 Mar 02; 122():108196. PubMed ID: 33221125
    [Abstract] [Full Text] [Related]

  • 44. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP, Presnall N, Stringfellow E, Wood C, Horn P, Duello A, Green L, Rudder T.
    Am J Drug Alcohol Abuse; 2019 Mar 02; 45(4):333-340. PubMed ID: 31084515
    [Abstract] [Full Text] [Related]

  • 45. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
    Shastry S, Nobel I, Allen LR, Richardson LD, Vidal K, Manini AF.
    Am J Emerg Med; 2022 Jan 02; 51():114-118. PubMed ID: 34735968
    [Abstract] [Full Text] [Related]

  • 46. An Appraisal of Using Opioids in Patients with Opioid Use Disorder.
    Smith RG.
    J Am Podiatr Med Assoc; 2023 Jan 02; 113(3):. PubMed ID: 37463194
    [Abstract] [Full Text] [Related]

  • 47. Systematic review on the clinical management of chronic pain and comorbid opioid use disorder.
    Jiménez-Fernández B, Calomarde-Gómez C, López-Lazcano A, Lligoña A, Gual A, López-Pelayo H.
    Adicciones; 2023 Jul 01; 35(2):197-212. PubMed ID: 35472158
    [Abstract] [Full Text] [Related]

  • 48. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G.
    Addiction; 2011 Jul 01; 106(7):1355-62. PubMed ID: 21438938
    [Abstract] [Full Text] [Related]

  • 49. Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report.
    Martell JP, Konakanchi JS, Sethi R.
    J Addict Dis; 2022 Jul 01; 40(3):439-443. PubMed ID: 35072589
    [Abstract] [Full Text] [Related]

  • 50. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.
    Camenga DR, Colon-Rivera HA, Muvvala SB.
    J Stud Alcohol Drugs; 2019 Jul 01; 80(4):393-402. PubMed ID: 31495374
    [Abstract] [Full Text] [Related]

  • 51. Acceptance of medications for opioid use disorder in recovery housing programs in Missouri.
    Wood CA, Duello A, Miles J, Lohmann B, Gochez-Kerr T, Richardson K, Anderson-Harper R, Winograd RP.
    J Subst Abuse Treat; 2022 Jul 01; 138():108747. PubMed ID: 35248406
    [Abstract] [Full Text] [Related]

  • 52. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
    Cochran G, Bruneau J, Cox N, Gordon AJ.
    Subst Abus; 2020 Jul 01; 41(3):269-274. PubMed ID: 32697171
    [Abstract] [Full Text] [Related]

  • 53. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM, Shoff C, Hodges K, Blanco C, Losby JL, Ling SM, Compton WM.
    JAMA Psychiatry; 2022 Oct 01; 79(10):981-992. PubMed ID: 36044198
    [Abstract] [Full Text] [Related]

  • 54. Medications for management of opioid use disorder.
    Koehl JL, Zimmerman DE, Bridgeman PJ.
    Am J Health Syst Pharm; 2019 Jul 18; 76(15):1097-1103. PubMed ID: 31361869
    [Abstract] [Full Text] [Related]

  • 55. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.
    Neumann AM, Blondell RD, Jaanimägi U, Giambrone AK, Homish GG, Lozano JR, Kowalik U, Azadfard M.
    J Addict Dis; 2013 Jul 18; 32(1):68-78. PubMed ID: 23480249
    [Abstract] [Full Text] [Related]

  • 56. Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients.
    Dunn KE, Finan PH, Tompkins DA, Fingerhood M, Strain EC.
    Drug Alcohol Depend; 2015 Dec 01; 157():143-9. PubMed ID: 26518253
    [Abstract] [Full Text] [Related]

  • 57. Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial.
    Hser YI, Zhu Y, Fei Z, Mooney LJ, Evans EA, Kelleghan A, Matthews A, Yoo C, Saxon AJ.
    Addiction; 2022 Jan 01; 117(1):151-161. PubMed ID: 34105213
    [Abstract] [Full Text] [Related]

  • 58. Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses.
    Andraka-Christou B, Totaram R, Randall-Kosich O.
    Subst Abus; 2022 Jan 01; 43(1):415-424. PubMed ID: 34214400
    [Abstract] [Full Text] [Related]

  • 59. Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
    Zhang P, Tossone K, Ashmead R, Bickert T, Bailey E, Doogan NJ, Mack A, Schmidt S, Bonny AE.
    J Subst Abuse Treat; 2022 May 01; 136():108686. PubMed ID: 34953637
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.